What You Should
Know:
Medable announced
$91 million in new funding to accelerate the life sciences industry’s shift to
digital and decentralized clinical trials, bringing Medable’s total capital
raised to more than $136M.
- Medable has played a pivotal role in enabling clinical trials during the COVID-19 pandemic, facilitating the continuation of existing research via remote care as well as accelerating the development of vaccines and therapeutics for COVID-19.
Medable,
Read More
Medable | Digitally Enabled Clinical Trials | News, Analysis, Insights - HIT Consultant
Medable Launches TeleConsent for Clinical Trials to Streamline Approvals During Decentralized Trials
What You Should Know:
- Medable launches Teleconsent, part of its Telehealth
family of cloud-based software for decentralized clinical trials.
- The application represents the next big step in
enabling fully virtual trials and is key to patient-centric trial design
because it allows patients to handle the lengthy process of consenting – and
re-consenting – to trial participation conveniently from anywhere.
Medable Inc.,
a software provider for decentralized clinical trials,
Read More
Medable Lands $25M to Expand Platform for Decentralized Clinical Trials
What You Should Know:
- Medable raises $25M in funding to expand global platform for decentralized clinical trials led by GSR Ventures, with additional investment from existing investor PPD, Inc.
- Founded in 2015, Medable’s global decentralized trial platform streamlines design, recruitment, retention and data quality, replacing siloed systems with integrated digital tools, data and interfaces to accelerate trial execution.
Medable, Inc., a Palo
Alto, CA-based global platform
Read More
Medable to Power UConn Virtual Study on Statin-Related Adverse Events
- The University of Connecticut (UConn) Department of Kinesiology and Hartford Healthcare is recruiting the help of Medable, a provider of digital trials to implement a cloud-based platform to evaluate statin-related adverse events called SAMS. - The virtual study helps monitor patient responses to statin medications via an app, and notify clinicians and patients when the patient should stop or start their medication based on presenting symptoms collected via electronic patient-reported
Read More
UPenn Taps Medable’s Digital Trials Platform to Power LITE Psoriasis Study
The University of Pennsylvania School of Medicine has partnered with Medable, a provider of digital trials platform to accelerate patient enrollment and increase patient retention in the Light Treatment Effectiveness (LITE) study, which evaluates home versus office-based narrowband ultraviolet B phototherapy for the treatment of psoriasis.Phase 4 Pragmatic StudyMedable’s direct-to-patient app was selected for LITE, a Phase 4 pragmatic study that will enroll 1050 patients across 20-40 clinical
Read More
Medable Joins the American Heart Association’s Center for Health Technology & Innovation Innovators Network
Medable Inc., a provider of digitally-enabled and data-driven clinical trials, will join the American Heart Association’s Center for Health Technology & Innovation (the Center) Innovators Network. The Center is focused on building health-tech relationships to drive innovative and scalable solutions across the health continuum.American Heart Association’s Center for Health Technology & Innovation Innovators NetworkThe Center helps members of its Innovators Network in the healthcare
Read More
Medable Launches Telemedicine Solution to Improve Data-Driven Virtual Clinical Trials
Medable Inc., a Silicon Valley-based provider of data driven and digitally enabled clinical trials has announced the launch of their global Trial-Fit™ Telemedicine Solution designed to address critical trial barriers of low patient retention and lack of access. Medable’s Trial-Fit Telemedicine enables sites all over the world to conduct secure, HIPAA-compliant video consultations with clinical study participants in an integrated eCOA solution. Medable telemedicine is the only integrated,
Read More
National Cancer Institute Awards Medable $3.5M in Grants to Develop Digital Care Platforms
Medable Awarded $3.5M in SBIR Fast-Track Grants from the National Cancer Institute to Develop Digital Platforms to Improve Patient Care
The National
Cancer Institute (NCI) has awarded Medable
Inc. an end-to-end platform for digitally enabled and data-driven clinical
trials two Fast-Track Small Business Innovation (SBIR) grants. The grants will
provide up to $3.5 million in nondilutive research funding over the next
several years to develop digital platforms to improve patient
Read More
Medable Unveils Blockchain for Healthcare Platform to Enable Medical Data Exchange
Medable Inc., the leading app and analytics platform for healthcare, at SXSW HealthSpark announced INSIGHT, a blockchain powered platform that enables medical data exchange among patients, medical researchers, and biopharmaceutical companies.Since its launch in late 2016, Medable has seen rapid adoption of its platform with a customer base that cares for over 15 million patients and conducts over 6,000 clinical trials. Using mobile devices and 3rd party tools like Apple’s Researchkit, Medable
Read More
Penn Medicine, Medable Unveil CareKit App for Bariatric Surgery Patients
Penn Medicine, today announced it is extending the use of mobile devices as a health tool to improve the patient experience and patient care by launching the Penn Life Gained app specifically for bariatric surgery patients at Penn Medicine, as part of the institution’s focus on mobile health and innovative research strategies. Developed by clinicians in the Bariatric Surgery Program and Penn’s Corporate Information Services team, in partnership with Medable, the app is built using the Apple
Read More
